TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

Item

http://www.wikidata.org/entity/Q42801713

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

@en

TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

@nl

type

Item

label

TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

@en

TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

@nl

prefLabel

TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

@en

TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

@nl

P1476

TriKEs and BiKEs join CARs on the cancer immunotherapy highway.

@en

P2093

Hernan Carol

http://www.w3.org/2001/XMLSchema#string

P2860

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity

Innate or adaptive immunity? The example of natural killer cells

Chimeric antigen receptor T cells for sustained remissions in leukemia

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.

P304

2790-2796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1198455

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maté Biro

Szun S Tay

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27322989

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5137511

http://www.w3.org/2001/XMLSchema#string